Weight-loss drug could reduce heart attack risk
A study presented at the European Congress of Obesity (ECO) has unveiled promising news for millions struggling with cardiovascular health. Researchers at University College London investigated the effects of semaglutide, a medication already used for weight loss under brand names Wegovy and Ozempic. The groundbreaking aspect? Participants taking semaglutide experienced a 20% lower risk of